Clinical Pathways at the Cancer Treatment Centers of America Offer Guidance for Doctors and Patients
Following a new partnership between Cancer Treatment Centers of America, NantHealth, and AllScripts, doctors and patients at all five Cancer Treatment Centers of America will have a library of data in which to research treatments. The partnership creates a seamless transition, called Clinical Pathways, which will allow for the free movement of information from the health database into a doctor’s office, without needing to interrupt the existing clinical schedule.
Clinical Pathways uses eviti, a clinical decision support solution developed by NantHealth, to reach the AllScripts Sunrise electronic health record. Hundreds of oncologists throughout the country have contributed to the clinical operating system’s database, and as a result, it is constantly evolving with new results in cutting edge cancer treatment.
All of the treatments in the database match the Cancer Treatment Centers of America standard of care. The Allscripts Sunrise EHR also includes complimentary therapies, which can help raise the quality of life for cancer patients.
During a visit, the doctor can access the Allscripts Sunrise EHR and explain the results to the patient in a user-friendly manner. The patient will be able to learn about customized treatment solutions for their specific disease state, the cost comparisons between different treatments, and the doctor can order treatments as needed.
Cancer Treatment Centers of America is headquartered in Boca Raton, Florida. They are a network of five cancer-treating hospitals which focus on a holistic approach, tackling the cancer issue in a way that addresses a patient’s unique genetic signature, as well as the emotional and physical struggles that come with cancer treatment.
They are highly rated in national studies for both quality of care and patient experiences. They encourage the active participation of their patients and families during every step of the treatment process, which will be enhanced by the new Clinical Pathways tool.
For more information follow CTCA on Twitter.